Cell News and Research

RSS

Immunocompromised patients show prolonged SARS-CoV-2 infection and unique mutations

study identifies risk factors for prolonged SARS-CoV-2 infection in immunocompromised patients, revealing that B-cell dysfunction, solid organ transplantation, and AIDS lead to longer infections and unique spike mutations.

31 Jan 2024

New project aims to increase the EU's ability to combat flavivirus threats

A new project - FLAVIVACCINE - aims to increase the EU's ability to combat epidemic and pandemic viral threats both in Europe and around the world.

31 Jan 2024

Combination drug treatment could be effective against malignant peripheral nerve sheath tumors

A combination of two cancer drugs could be effective against malignant peripheral nerve sheath tumors (MPNSTs) - soft tissue tumors that are stubbornly resistant to chemotherapy and radiation - according to a laboratory study led by researchers at the Johns Hopkins Kimmel Cancer Center.

31 Jan 2024

AI-based applications for personalized cancer medicine and related regulatory challenges: An overview

Personalized therapies could improve the treatment of many diseases in the future. Cancer medicine in particular has made significant progress in recent years.

31 Jan 2024

Study explores the mediatory role of gut microbiota in metabolic syndrome and sleep disorders

Researchers described gut microbiota and metabolic alterations common to metabolic syndrome (MetS) and sleep disorders.

31 Jan 2024

Immune protein Ku70 key in fighting bowel cancer

Study establishes Ku70's role in tumor suppression, showing that reduced expression or mutations in this DNA repair protein significantly increase intestinal cancer risk.

30 Jan 2024

Ancient genomes unearth degenerate transposable elements in human DNA

The human genome, an intricate tapestry of genetic information for life, has proven to be a treasure trove of strange features. Among them are segments of DNA that can "jump around" and move within the genome, known as "transposable elements" (TEs).

30 Jan 2024

XRCC1 shows potential as a prognostic and immunological pan-cancer biomarker

A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 16, Issue 1, entitled, "XRCC1: a potential prognostic and immunological biomarker in LGG based on systematic pan-cancer analysis."

30 Jan 2024

Prebiotic inulin may ease muscle loss in burn victims, study suggests

Inulin supplementation was found to mitigate gut microbiota dysbiosis and skeletal muscle atrophy in rats with severe burns, suggesting a promising approach for improving burn recovery outcomes.

30 Jan 2024

Study unmasks secrets of glioma's invasive margins

High-grade gliomas are cancerous tumors that spread quickly in the brain or spinal cord.

30 Jan 2024

Weill Cornell Medicine researcher wins $2.1 million grant to study repetitive DNA and RNA sequences

Dr. Jeannine Gerhardt, an assistant professor of stem cell biology in obstetrics and gynecology and in reproductive medicine at Weill Cornell Medicine, has received a five-year, $2.1 million grant from the National Institute of General Medical Sciences (NIGMS), part of the National Institutes of Health, for the study of repetitive DNA and RNA sequences and the mechanisms by which they cause cell dysfunction and diseases.

30 Jan 2024

Vegan and keto diets trigger distinct immune system changes in just two weeks

Researchers at the National Institutes of Health observed rapid and distinct immune system changes in a small study of people who switched to a vegan or a ketogenic (also called keto) diet.

30 Jan 2024

Gut microbiome may hold key to fighting common respiratory viruses

The composition of microbiota found in the gut influences how susceptible mice are to respiratory virus infections and the severity of these infections, according to researchers from the Center for Translational Antiviral Research in the Institute for Biomedical Sciences at Georgia State University.

30 Jan 2024

Gene therapy could prolong survival in some people with arrhythmogenic right ventricular cardiomyopathy

A new study in mice shows that replacement of a dysfunctional gene could prolong survival in some people with arrhythmogenic right ventricular cardiomyopathy (ARVC), a rare inherited disorder in which the muscular walls of the heart progressively weaken and put patients at risk of dangerous irregular heartbeats.

30 Jan 2024

New DNA-based vaccine can induce strong antibody response against SARS-CoV-2

Using a virus-like delivery particle made from DNA, researchers from MIT and the Ragon Institute of MGH, MIT, and Harvard have created a vaccine that can induce a strong antibody response against SARS-CoV-2.

30 Jan 2024

Resin ingredient strongly decreases coronavirus infectivity on plastic surfaces

Researchers at the University of Jyväskylä, Finland, are currently developing anti-viral surfaces to decrease the spread of infectious diseases.

30 Jan 2024

Cambridge scientists discover how fasting turns up the body's natural inflammation fighter

Cambridge scientists may have discovered a new way in which fasting helps reduce inflammation – a potentially damaging side-effect of the body's immune system that underlies a number of chronic diseases.

30 Jan 2024

Nature walk enhances certain executive control processes in the brain

New research from University of Utah psychology researchers is helping prove what American authors John Muir and Henry David Thoreau tried to teach more than 150 years ago: Time spent in nature is good for the heart and soul.

30 Jan 2024

Genetic blueprint revealed: New insights into thyroid cancer's resistance and transformation

A new research perspective was published in Oncotarget's Volume 15 on January 24, 2024, entitled, "Genetic alterations in thyroid cancer mediating both resistance to BRAF inhibition and anaplastic transformation."

30 Jan 2024

"Zombie" viral fragments trigger inflammation to cause serious COVID-19 outcomes

There are many lingering mysteries from the COVID-19 pandemic. For instance, why does SARS-CoV-2, the virus behind the disease, cause severe symptoms in some patients, while many other coronaviruses don't? And what causes strange symptoms to persist even after the infection has been cleared from a person's system?

30 Jan 2024

Cell News and Research

Immunocompromised patients show prolonged SARS-CoV-2 infection and unique mutations

New project aims to increase the EU's ability to combat flavivirus threats

Combination drug treatment could be effective against malignant peripheral nerve sheath tumors

AI-based applications for personalized cancer medicine and related regulatory challenges: An overview

Study explores the mediatory role of gut microbiota in metabolic syndrome and sleep disorders

Immune protein Ku70 key in fighting bowel cancer

Ancient genomes unearth degenerate transposable elements in human DNA

XRCC1 shows potential as a prognostic and immunological pan-cancer biomarker

Prebiotic inulin may ease muscle loss in burn victims, study suggests

Study unmasks secrets of glioma's invasive margins

Weill Cornell Medicine researcher wins $2.1 million grant to study repetitive DNA and RNA sequences

Vegan and keto diets trigger distinct immune system changes in just two weeks

Gut microbiome may hold key to fighting common respiratory viruses

Gene therapy could prolong survival in some people with arrhythmogenic right ventricular cardiomyopathy

New DNA-based vaccine can induce strong antibody response against SARS-CoV-2

Resin ingredient strongly decreases coronavirus infectivity on plastic surfaces

Cambridge scientists discover how fasting turns up the body's natural inflammation fighter

Nature walk enhances certain executive control processes in the brain

Genetic blueprint revealed: New insights into thyroid cancer's resistance and transformation

"Zombie" viral fragments trigger inflammation to cause serious COVID-19 outcomes

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo